
Waters is the brand name of Waters Corporation (NYSE: WAT), the publicly traded American analytical laboratory instruments and software company headquartered in Milford, Massachusetts. Founded in 1958 by James Waters, it is a global leader in liquid chromatography, mass spectrometry, and thermal analysis, serving pharmaceutical, life sciences, and materials science customers with about 2.9 billion dollars in annual revenue.
Parent Company
Founded
1958
Status
Publicly Traded
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Waters | Waters Corporation | Product line |
James Waters founded the company in 1958 in Framingham, Massachusetts, as an engineering shop producing laboratory equipment. Its defining breakthrough came in 1963 with the GPC100, the first commercially successful gel permeation chromatograph, which established liquid chromatography as the company's core field.
The 1970s and 1980s made Waters synonymous with high-performance liquid chromatography. Its HPLC systems became the analytical standard in pharmaceutical laboratories, and the company pioneered the instruments, columns, and software that turned chromatography from a specialist technique into routine laboratory infrastructure.
Waters went public on the New York Stock Exchange in 1995 and spent the following decades building out its portfolio. The 1996 acquisition of Micromass brought it into mass spectrometry, which grew into its second core technology line. TA Instruments, acquired in 1996, added thermal analysis. Informatics software, including the Empower chromatography data system, became the glue binding instruments into workflows.
Through the 2000s and 2010s Waters consolidated its position as a leading analytical science company, growing revenue steadily through pharmaceutical industry demand, life sciences research, and food and environmental testing markets. Its Milford, Massachusetts headquarters remained the center of an operation that grew to several thousand employees worldwide.
The 2020s brought both continuity and change. The company continued launching new chromatography and mass spectrometry platforms, and it moved toward integrating advanced software and AI-driven analytics into its instrument ecosystems. Revenue reached about 2.9 billion dollars in FY2024, with growth driven by pharmaceutical and biopharma demand for its core technologies.
Its market has also shifted under competitive and technological pressure, with rivals advancing mass spectrometry and the rise of new analytical modalities, but Waters retains its leadership in liquid chromatography and its entrenched position in pharmaceutical quality control worldwide.
Is Waters Corporation publicly traded?
Yes. Waters Corporation trades on the New York Stock Exchange under ticker WAT. It went public in November 1995 and is an S&P 500 constituent.
Who founded Waters Corporation?
James Logan Waters founded the company as Waters Associates in 1958 in Framingham, Massachusetts. He was a physicist who had previously worked at Raytheon.
What happened with Waters and BD?
Waters completed a combination with BD's Biosciences and Diagnostic Solutions business on 9 February 2026. The deal valued the BD business at about 18.8 billion dollars, paid BD 4 billion dollars in cash, and gave former BD shareholders 39.2 percent of the combined company.
What does Waters Corporation make?
It makes analytical instruments and consumables, primarily liquid chromatography and mass spectrometry systems, LC columns and chemistry products, the Empower software platform, and thermal analysis instruments under TA Instruments. Post-BD it also makes flow cytometry, molecular diagnostics, and microbiology testing products.
Where is Waters Corporation headquartered?
Waters is headquartered at 34 Maple Street in Milford, Massachusetts, USA, and operates in more than 100 countries.
How much revenue does Waters make?
Waters reported revenue of 3.165 billion dollars for fiscal year 2025. Including the acquired BD business, the combined company has a pro forma revenue base of roughly 6.3 billion dollars.
Waters has faced no major scandal or regulatory action as of November 2026. As a scientific instruments company its exposure is product quality and data integrity rather than the conduct controversies that affect consumer or pharmaceutical companies, and its compliance record reflects the regulated nature of its customers' industries.
Routine product field actions and quality notices occur in the normal course of a precision instruments business, but nothing has defined the company negatively in public record.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | USA | 2006 | Mass market | Global | All Genders |
Market Positioning: Waters competes with 1 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by Waters Corporation, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by BMG Labtech GmbH
German life-science instrumentation company focused exclusively on microplate readers. Family-owned, founded in 1989, and based in Ortenberg, Germany.
BMG LABTECH is privately owned, unlike Waters which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by TTAM Research Institute
Consumer DNA testing brand now run as a nonprofit under TTAM Research Institute following the 2025 bankruptcy sale of 23andMe Holding Co.
23andMe is privately owned, unlike Waters which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Adcock Ingram Holdings Limited
South African pharmaceutical brand behind Panado and Myprodol, now privately held by Bidvest and NATCO Pharma.
Adcock Ingram is privately owned, unlike Waters which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Alfa-Pharm CJSC
Armenia's largest pharmaceutical distributor and pharmacy chain, importing medicines from more than 70 global manufacturers since 1996.
Alfa-Pharm is privately owned, unlike Waters which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by All Family Pharmacy LLC
Boca Raton mail-order pharmacy at allfamilypharmacy.com known for direct-to-consumer access to ivermectin, hydroxychloroquine, and 200-plus medications.
All Family Pharmacy is privately owned, unlike Waters which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Arthrex Inc.
Orthopedic device brand of privately held Arthrex Inc., specializing in arthroscopic surgery products sold in more than 100 countries.
Arthrex is privately owned, unlike Waters which is under a publicly traded parent company.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Consumer DNA testing brand now run as a nonprofit under TTAM Research Institute following the 2025 bankruptcy sale of 23andMe Holding Co.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Abbott Laboratories' medical device business spanning cardiovascular, diabetes care (FreeStyle Libre), neuromodulation, and structural heart, generating roughly $20 billion annually.